Patents by Inventor Timothy Dungan

Timothy Dungan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phenylephrine formulations with improved stability
    Patent number: 10130627
    Abstract: A pharmaceutical composition includes a pharmaceutical polysaccharide and phenylephrine hydrochloride. The ratio of said polysaccharide to phenylephrine hydrochloride is sufficient to dilute the composition such that phenylephrine hydrochloride is stable at high temperature and humidity.
    Type: Grant
    Filed: June 3, 2015
    Date of Patent: November 20, 2018
    Assignee: GlaxoSmithKine Consumer Healthcare S.A.
    Inventors: Timothy Dungan, Brian Warrington
  • PHENYLEPHRINE FORMULATIONS WITH IMPROVED STABILITY
    Publication number: 20160015815
    Abstract: A pharmaceutical composition includes a pharmaceutical polysaccharide and phenylephrine hydrochloride. The ratio of said polysaccharide to phenylephrine hydrochloride is sufficient to dilute the composition such that phenylephrine hydrochloride is stable at high temperature and humidity.
    Type: Application
    Filed: May 29, 2015
    Publication date: January 21, 2016
    Applicant: Novartis AG
    Inventors: Timothy DUNGAN, Brian WARRINGTON
  • Phenylephrine Formulations With Improved Stability
    Publication number: 20150265713
    Abstract: A pharmaceutical composition includes a pharmaceutical polysaccharide and phenylephrine hydrochloride. The ratio of said polysaccharide to phenylephrine hydrochloride is sufficient to dilute the composition such that phenylephrine hydrochloride is stable at high temperature and humidity.
    Type: Application
    Filed: June 3, 2015
    Publication date: September 24, 2015
    Inventors: Timothy DUNGAN, Brian WARRINGTON
  • PHEHYLEPHRINE FORMULATIONS WITH IMPROVEDS STABILITY
    Publication number: 20110237616
    Abstract: A pharmaceutical composition includes a pharmaceutical polysaccharide and phenylephrine hydrochloride. The ratio of said polysaccharide to phenylephrine hydrochloride is sufficient to dilute the composition such that phenylephrine hydrochloride is stable at high temperature and humidity.
    Type: Application
    Filed: December 11, 2009
    Publication date: September 29, 2011
    Applicant: Novartis AG
    Inventors: Timothy Dungan, Brian Warrington